Defiant Elementis reinstates dividend

Macro uncertainty persists, but the company itself is in better health

March 7, 2024

Leverage reduced
Profits up despite falling sales

Chemicals group Elementis (ELM) has spent much of the past few months dodging takeover attempts and ignoring calls by activist investors to initiate an immediate sale.

This is subscriber only content

Start your trial to keep reading

PRINT AND DIGITAL trial

Get 12 weeks for £12

Essential access to the website and app
Magazine delivered every week
Investment ideas, tools and analysis

Have an account? Sign in